• About us
• Contact

Advertisement

Organisation › Details

Standard BioTools (Group)

Standard BioTools Inc. (Nasdaq:LAB), the parent company of SomaLogic Inc. and previously known as Fluidigm Corporation, has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. *

 

	Start	2022-04-04 renamed
	Predecessor	Fluidigm (Group)
	Industry	microfluidics technology
	Person	Egholm, Michael (Fluidigm 2022Q2– CEO before Danaher Life Sciences + Pall + 454 Life Sciences + Molecular Staging)
	Person 2	Jog, Vikram (Fluidigm 200802– CFO before XDx CFO + Applera)
	Region	South San Francisco, CA
	Country	United States (USA)
	Street	2 Tower Place Suite 2000
	City	94080 South San Francisco, CA
		Address record changed: 2024-08-12
Basic data	Employees	E: 501 to 1,000 (2023-12-31)
	Currency	USD
	Annual sales	106,340,000 (revenue, total, consolidated (2019) 2023-12-31)
	Profit	-74,656,000 (2023-12-31)
	Cash	114,895,000 (2023-12-31)
		* Document for »About Section«: Standard BioTools Inc.. (8/6/24). "Press Release: Standard BioTools to Participate in Upcoming Investor Conferences". South San Francisco, CA.
		Record changed: 2024-08-12

Advertisement

More documents for Standard BioTools (Group)

• [1] Standard BioTools Inc.. (8/6/24). "Press Release: Standard BioTools to Participate in Upcoming Investor Conferences". South San Francisco, CA....
• [2] Standard BioTools Inc.. (1/5/24). "Press Release: Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools". South San Francisco, CA & Boulder, CO....
• [3] Standard BioTools Inc.. (10/4/23). "Press Release: Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools". South San Francisco, CA & Boulder, CO....
• [4] Fluidigm Corporation. (4/4/22). "Press Release: Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.". South San Francisco, CA....
• [5] Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA....
• [6] Fluidigm Corporation. (3/28/22). "Press Release: Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution". South San Francisco, CA....
• [7] Fluidigm Corporation. (1/24/22). "Press Release: Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.". South San Francisco, CA....
• [8] Fluidigm Corporation. (9/2/21). "Press Release: Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference". South San Francisco, CA....
• [9] SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO....
• [10] Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.